Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Cytokine|November 13, 2012
Interleukin-10 activates Toll-like receptor 4 and requires MyD88 for cardiomyocyte survivalAshim K Bagchi, Anita Sharma, Sanjiv Dhingra, et al.
Clinical Interventions in Aging|March 8, 2013
Effects of balance training using a virtual-reality system in older fallersGustavo Duque, Derek Boersma, Griselda Loza-Diaz, et al.
BMC Medicine|July 3, 2024
Acceptability of data linkage to identify women at risk of postnatal complication for the development of digital risk prediction tools and interventions to better optimise postnatal care, a qualitative descriptive study designSiobhán O'Connor, George Tilston, Olivia Jones, et al.
Environmental Research|March 31, 2022
Indigenous bacterial consortium-mediated cypermethrin degradation in the presence of organic amendments and Zea mays plantsPankaj Bhatt, Eldon R Rene, Yaohua Huang, et al.
Plos One|February 8, 2023
Combinations of medicines in patients with polypharmacy aged 65-100 in primary care: Large variability in risks of adverse drug related and emergency hospital admissionsAli Fahmi, David Wong, Lauren Walker, et al.
The Indian Journal of Medical Research|May 6, 2017
Scrub typhus in Uttarakhand & adjoining Uttar Pradesh: Seasonality, clinical presentations & predictors of mortalityAnurag Bhargava, Reshma Kaushik, Rajeev Mohan Kaushik, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|April 25, 2007
TNFalpha-308G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian populationIndu Kohaar, Nisha Thakur, Sudha Salhan, et al.
Journal of Clinical Psychopharmacology|February 28, 2012
Effects of drug burden index on cognitive function in older menDanijela Gnjidic, David G Le Couteur, Vasi Naganathan, et al.
Disease Markers|August 5, 2010
Genetic polymorphism of glutathione S transferases M1 and T1 in Indian patients with hepatocellular carcinomaMohammad Asim, Luqman A Khan, S A Husain, et al.
The Canadian Journal of Cardiology|February 4, 2014
Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin- and trastuzumab-mediated cardiomyopathyMatthew Zeglinski, Sheena Premecz, Jordyn Lerner, et al.
Pageof 14